Everstar Asset Management LLC Boosts Stock Position in The Clorox Company $CLX

Posted by Stanley Muller on May 16th, 2026

Everstar Asset Management LLC boosted its holdings in The Clorox Company (NYSE:CLX – Free Report) by 259.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 24,183 shares of the company’s stock after purchasing an additional 17,452 shares during the quarter. Clorox makes up approximately 1.2% of Everstar Asset Management LLC’s holdings, making the stock its 16th largest position. Everstar Asset Management LLC’s holdings in Clorox were worth $2,438,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. 1620 Investment Advisors Inc. acquired a new stake in Clorox during the fourth quarter worth approximately $159,000. Stephens Inc. AR raised its holdings in Clorox by 38.3% during the fourth quarter. Stephens Inc. AR now owns 6,443 shares of the company’s stock worth $679,000 after purchasing an additional 1,784 shares in the last quarter. AlphaCore Capital LLC raised its holdings in Clorox by 74.7% during the fourth quarter. AlphaCore Capital LLC now owns 6,494 shares of the company’s stock worth $655,000 after purchasing an additional 2,776 shares in the last quarter. Commerzbank Aktiengesellschaft FI raised its holdings in Clorox by 3.5% during the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 14,585 shares of the company’s stock worth $1,471,000 after purchasing an additional 500 shares in the last quarter. Finally, Convergence Investment Partners LLC acquired a new stake in Clorox during the fourth quarter worth approximately $1,203,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX opened at $90.47 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The firm has a market cap of $10.94 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 0.47 and a beta of 0.59. The company’s 50 day simple moving average is $101.99 and its 200-day simple moving average is $106.96. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $136.69.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm posted $1.45 earnings per share. The company’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts predict that The Clorox Company will post 5.63 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were issued a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.5%. Clorox’s dividend payout ratio (DPR) is currently 80.52%.

Insider Activity

In related news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.63% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

CLX has been the topic of several research reports. Jefferies Financial Group dropped their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Royal Bank Of Canada dropped their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. UBS Group dropped their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Citigroup dropped their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, Morgan Stanley dropped their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $103.73.

Check Out Our Latest Stock Analysis on CLX

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.